Bloom Energy stock jumps again: BE extends rally on $600 million Wells Fargo credit line as jobs report looms
5 January 2026
1 min read

Bloom Energy stock jumps again: BE extends rally on $600 million Wells Fargo credit line as jobs report looms

New York, January 5, 2026, 11:31 EST — Regular session

Bloom Energy Corporation (BE) shares were up 6.3% at $104.95 in mid-morning trading on Monday, after ending Friday at $98.69. The fuel-cell maker’s stock has traded between $100.32 and $107.24 so far in the regular session.

The rally has refocused attention on Bloom’s $600 million senior secured multicurrency revolving credit facility — a bank line companies can draw and repay — that it put in place with Wells Fargo, a filing showed. The facility matures in December 2030, is secured by a lien on most of Bloom’s personal property (excluding intellectual property), and carries floating-rate pricing tied to Term SOFR, a benchmark interest rate, plus a margin linked to leverage. Proceeds can fund working capital and capital spending, while the agreement sets leverage and interest-coverage tests and restricts dividends and additional debt, the filing said. 1

That matters because Bloom has traded like a rate-sensitive momentum name, leaving it exposed to swings in bond yields and investor risk appetite. “The market is looking for direction,” said Matthew Maley, chief market strategist at Miller Tabak, as investors weigh the outlook for interest rates heading into key data and earnings. 2

A revolving facility does not add cash until it is tapped, but it can reduce pressure to raise money quickly if orders or working-capital needs jump. It is also floating-rate debt, meaning interest expense can move quickly when policy expectations shift.

Bloom, based in San Jose, California, sells solid oxide fuel-cell systems that generate electricity through an electrochemical process rather than combustion, typically using natural gas with the option to run on other fuels. Customers use them for on-site power where reliability matters and grid upgrades can take time.

Other U.S.-listed fuel-cell stocks were mixed. Plug Power rose 3.8%, Ballard Power added 1.1% and FuelCell Energy slipped 1.2%.

The broader risk backdrop was supportive, with the SPDR S&P 500 ETF Trust up about 0.8% and the Invesco QQQ Trust up about 1.2%. That helped keep money flowing into higher-volatility trades.

For Bloom, the $100 handle is back in view — a round number that often acts as a short-term pivot for traders. Monday’s low stayed just above it, while a push through $107 showed buyers still have room to lean into momentum.

But the move cuts both ways: if Bloom taps the line heavily, it could add secured debt at a floating cost, and covenant pressure can tighten as leverage rises. The fuel-cell group also remains prone to sharp reversals when sentiment turns against capital-intensive clean-power plays.

Stock Market Today

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
UnitedHealth stock ticks up after Barclays target hike as UNH earnings near
Previous Story

UnitedHealth stock ticks up after Barclays target hike as UNH earnings near

EOSE stock rises as Eos Energy extends storage trade; options buzz keeps traders on edge
Next Story

EOSE stock rises as Eos Energy extends storage trade; options buzz keeps traders on edge

Go toTop